EXPD
37
-2
KEY
31
2
NWL
62
-3
STX
42
-2
CMG
69
-4
UNH
44
2
NEM
46
-2
BIIB
38
-2
UHS
52
2
MAC
67
2
EA
50
-2
AKAM
59
-2
AN
50
-5
RL
75
3
HUM
33
2
WFC
58
-2
JBHT
53
-3
EMC
71
3
FSLR
63
5
CSCO
61
-3
EXPD
37
-2
KEY
31
2
NWL
62
-3
STX
42
-2
CMG
69
-4
UNH
44
2
NEM
46
-2
BIIB
38
-2
UHS
52
2
MAC
67
2
EA
50
-2
AKAM
59
-2
AN
50
-5
RL
75
3
HUM
33
2
WFC
58
-2
JBHT
53
-3
EMC
71
3
FSLR
63
5
CSCO
61
-3
Financhill
Back

Clinuvel Pharmaceuticals Quote, Financials, Valuation and Earnings

The dark truth about AI

Click here to learn more...
Sell
20

CLVLY
Clinuvel Pharmaceuticals

Last Price:
7.91
Seasonality Move:
0.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Clinuvel Pharmaceuticals Price Quote

$7.91
+0.00 (+1.02%)
(Updated: December 14, 2024 at 5:28 AM ET)

Clinuvel Pharmaceuticals Key Stats

Sell
20
Clinuvel Pharmaceuticals (CLVLY) is a Sell
Day range:
$7.83 - $8.05
52-week range:
$7.83 - $11.43
Dividend yield:
0.43%
P/E ratio:
17.28
P/S ratio:
6.97
P/B ratio:
2.92%
Volume:
2.5K
Avg. volume:
3.2K
1-year change:
-28.78%
Market cap:
$395.7M
Revenue:
$57.8M
EPS:
$0.46

How Much Does Clinuvel Pharmaceuticals Make?

Is Clinuvel Pharmaceuticals Growing As A Company?

Data Unavailable

Clinuvel Pharmaceuticals Stock Price Performance

What Is Clinuvel Pharmaceuticals 52-Week High & Low?

Clinuvel Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Clinuvel Pharmaceuticals?

Is Clinuvel Pharmaceuticals Cash Flow Positive?

Data Unavailable

Clinuvel Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    CLVLY return on invested capital is 19.13%
  • What Is Clinuvel Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 16.45%
  • What Is CLVLY Return On Equity?
    ROE is a measure of profitability and is 19.16%

Clinuvel Pharmaceuticals Earnings Date & Stock Price

Clinuvel Pharmaceuticals Competitors

Clinuvel Pharmaceuticals Dividend Yield

Clinuvel Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many CLVLY shares are owned by institutional investors?
    0 CLVLY shares are owned by institutional investors
  • How many CLVLY shares are owned by insiders?
    0 CLVLY shares are owned by insiders